Continuous Aspiration Thrombectomy in High- and Intermediate-High-Risk Pulmonary Embolism in Real-World Clinical Practice.


Journal

Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826

Informations de publication

Date de publication:
2020
Historique:
received: 02 04 2020
revised: 15 05 2020
accepted: 06 07 2020
entrez: 9 9 2020
pubmed: 10 9 2020
medline: 26 1 2021
Statut: epublish

Résumé

We sought to assess the technical and clinical feasibility of continuous aspiration catheter-directed mechanical thrombectomy (CDT) in patients with high- or intermediate-high-risk pulmonary embolism (PE). Fourteen patients (eight women and six men; age range: 29-71 years) with high- or intermediate-high-risk PE and contraindications to or ineffective systemic thrombolysis were prospectively enrolled between October 2018 and February 2020. The Indigo Mechanical Thrombectomy System (Penumbra, Inc., Alameda, California) was used as CDT device. Low-dose local thrombolysis (alteplase, 3-12 mg) was additionally applied in three patients. Technical and procedural success was achieved in 14 patients (100%). Complete or nearly complete clearance of pulmonary arteries was achieved in nine patients (64.3%), whereas partial clearance was achieved in five (35.7%). A significant improvement in the pre- and postprocedural patients' clinical status was observed in the following fields (median; interquartile range): heart rate (110; 100-120/min vs. 85; 80-90/min; CDT is a feasible and promising technique for management of high- or intermediate-high-risk PE to decrease thrombus burden, reduce right heart strain, and improve hemodynamic and clinical status. Some patients may benefit from simultaneous local low-dose thrombolytic therapy. Nevertheless, its criteria and role in CTD-managed patients require further elucidation.

Identifiants

pubmed: 32904502
doi: 10.1155/2020/4191079
pmc: PMC7456496
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4191079

Informations de copyright

Copyright © 2020 Aleksander Araszkiewicz et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Vasc Interv Radiol. 2018 Jul;29(7):993-997
pubmed: 29859664
Int J Cardiol. 2019 Jul 15;287:106-110
pubmed: 30846255
Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k
pubmed: 25173341
Respiration. 2013;85(5):408-16
pubmed: 23147354
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
JACC Cardiovasc Interv. 2019 May 13;12(9):859-869
pubmed: 31072507
N Engl J Med. 2014 Apr 10;370(15):1402-11
pubmed: 24716681
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Chest. 2016 Jul;150(1):35-45
pubmed: 26905364
Kardiol Pol. 2019;77(2):228-231
pubmed: 30566224
JACC Cardiovasc Interv. 2015 Aug 24;8(10):1382-92
pubmed: 26315743
Pol Arch Intern Med. 2018 Jun 30;128(6):394-395
pubmed: 29806658
Am J Med. 2012 May;125(5):465-70
pubmed: 22325236
Semin Intervent Radiol. 2018 Jun;35(2):92-98
pubmed: 29872243
Postepy Kardiol Interwencyjnej. 2019;15(4):497-498
pubmed: 31933670
Circulation. 2019 Nov 12;140(20):e774-e801
pubmed: 31585051
Eur J Cardiothorac Surg. 2012 Nov;42(5):S45-60
pubmed: 23026738
EuroIntervention. 2018 Feb 20;13(14):1721-1727
pubmed: 29175770
Kardiol Pol. 2018;76(9):1381
pubmed: 30211948
Semin Intervent Radiol. 2018 Jun;35(2):129-135
pubmed: 29872249
Chest. 2016 Aug;150(2):384-93
pubmed: 27006156
J Vasc Interv Radiol. 2018 Jan;29(1):101-106
pubmed: 29102272
JAMA. 2014 Jun 18;311(23):2414-21
pubmed: 24938564
Kardiol Pol. 2015;73(1):63-8
pubmed: 25625343
Kardiol Pol. 2020 Apr 24;78(4):300-310
pubmed: 32165606
Cardiol J. 2019;26(6):623-632
pubmed: 31970735
Circulation. 2014 Jan 28;129(4):479-86
pubmed: 24226805
Am J Med. 2014 Sep;127(9):829-39.e5
pubmed: 24813864
Hosp Pract (1995). 2014 Feb;42(1):31-7
pubmed: 24566594
Cardiovasc Intervent Radiol. 2018 Dec;41(12):1840-1848
pubmed: 29980817
Br Med J. 1971 Jun 19;2(5763):681-4
pubmed: 5556052
J Vasc Interv Radiol. 2017 Oct;28(10):1348-1352
pubmed: 28941516
Med Sci Monit. 2019 Jun 26;25:4734-4743
pubmed: 31239433
Vasc Endovascular Surg. 2018 Apr;52(3):195-201
pubmed: 29436310
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2363-71
pubmed: 25304324

Auteurs

Aleksander Araszkiewicz (A)

1 Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

Sylwia Sławek-Szmyt (S)

1 Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

Stanisław Jankiewicz (S)

1 Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

Bartosz Żabicki (B)

Department of Vascular Surgery, Collegium Medicum of Zielona Gora University, 65-417 Zielona Gora, Poland.

Marek Grygier (M)

1 Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

Tatiana Mularek-Kubzdela (T)

1 Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

Zbigniew Krasiński (Z)

Department of Vascular, Endovascular Surgery, Angiology and Phlebology, Poland.

Maciej Lesiak (M)

1 Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH